Hidden Potential: Turning Today’s Science into Tomorrow’s Cures
Monday, June 15, 2026 8:00 AM to 10:00 AM · 2 hr. (America/New_York)
TBD
00: Plenary03: Data-Tech-AI05: PersonalizedMed-ComboProd-Diagnostics08: RegPolicy-Strategy-GlobalCollaboration
Information
This opening plenary explores how patient driven science, AI enabled discovery, and regulatory innovation can uncover “hidden cures” in the medicines and data we already have. Through a keynote from David Fajgenbaum and a panel on AI in biopharma, the session asks how we can find, trust, and deliver tomorrow’s cures from today’s science.
Session Level
Intermediate
Featured Topics
Digital Enablement and Modernization
Learning Objectives
Describe the latent potential of existing medicines and data, and how patient driven science can uncover new uses for known therapies; Explain how AI and advanced analytics can de risk drug discovery and trial design, surfacing overlooked opportunities and improving investment decisions; Identify system level levers: collaboration, regulation, and capital, that can help translate today’s science into tomorrow’s cures more quickly, safely, and equitably.
Speakers
Maria Vassileva
Chief Science and Regulatory OfficerDIA
David Fajgenbaum
Co-Founder & President of Every CureEvery Cure
Rahul Gupta
PresidentGATC Health
Tomas Philipson
Daniel Levin Professor of Public Policy StudiesUniversity of ChicagoGS
Greg Sarafin
Sarafin Advisory
Audrey Greenberg
Venture PartnerMayo Venture Partner & Chair
